Latest ACell Stories
HRT’s advanced HydraTek® process has produced an extensive allograft product offering, including a variety of amniotic membrane configurations, a cryo-preserved flowable placental tissue
Research Shows Promise in Reducing Complications of Gastrointestinal Surgery COLUMBIA, Md., Dec. 9, 2014 /PRNewswire/ -- ACell, Inc.
COLUMBIA, Md., July 15, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today
SARASOTA, Fla., May 30, 2014 /PRNewswire-iReach/ -- On Friday, April 18(th) PGFX Patent Holdings, operating as Heritage Biosciences, LLC made an asset acquisition of proprietary methods, devices
New contract broadens access of MatriStem to an additional 100,000 healthcare entities COLUMBIA, Md., March 31, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company
CME-credited Event to Leverage Broad UBM Clinical Experience for Expanded Awareness COLUMBIA, Md., March 26, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company
Solution for deep, hard-to-heal wounds with additional contouring functionality COLUMBIA, Md., Feb.
Offers broad range of regenerative therapy solutions COLUMBIA, Md., Feb.
COLUMBIA, Md., Jan.
- A woman chauffeur.
- A woman who operates an automobile.